全文获取类型
收费全文 | 37343篇 |
免费 | 2638篇 |
国内免费 | 2856篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 544篇 |
妇产科学 | 123篇 |
基础医学 | 2567篇 |
口腔科学 | 34篇 |
临床医学 | 4440篇 |
内科学 | 11398篇 |
皮肤病学 | 160篇 |
神经病学 | 215篇 |
特种医学 | 2671篇 |
外科学 | 8029篇 |
综合类 | 4604篇 |
预防医学 | 1540篇 |
眼科学 | 21篇 |
药学 | 2901篇 |
12篇 | |
中国医学 | 1244篇 |
肿瘤学 | 2310篇 |
出版年
2024年 | 33篇 |
2023年 | 513篇 |
2022年 | 1105篇 |
2021年 | 1380篇 |
2020年 | 1245篇 |
2019年 | 1097篇 |
2018年 | 1123篇 |
2017年 | 965篇 |
2016年 | 1219篇 |
2015年 | 1372篇 |
2014年 | 2612篇 |
2013年 | 2253篇 |
2012年 | 2384篇 |
2011年 | 2465篇 |
2010年 | 2272篇 |
2009年 | 2335篇 |
2008年 | 2376篇 |
2007年 | 2303篇 |
2006年 | 2199篇 |
2005年 | 1791篇 |
2004年 | 1256篇 |
2003年 | 1114篇 |
2002年 | 1008篇 |
2001年 | 882篇 |
2000年 | 751篇 |
1999年 | 610篇 |
1998年 | 538篇 |
1997年 | 488篇 |
1996年 | 409篇 |
1995年 | 391篇 |
1994年 | 378篇 |
1993年 | 271篇 |
1992年 | 242篇 |
1991年 | 183篇 |
1990年 | 152篇 |
1989年 | 149篇 |
1988年 | 135篇 |
1987年 | 90篇 |
1986年 | 80篇 |
1985年 | 90篇 |
1984年 | 66篇 |
1983年 | 39篇 |
1982年 | 62篇 |
1981年 | 63篇 |
1980年 | 47篇 |
1979年 | 41篇 |
1978年 | 52篇 |
1977年 | 37篇 |
1976年 | 35篇 |
1974年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
Diabetes mellitus(DM) negatively affects the development and progression of chronic liver diseases(CLD) of various etiologies. Concurrent DM and CLD are also associated with worse clinical outcomes with respect to mortality, the occurrence of hepatic decompensation, and the development of hepatocellular carcinoma(HCC). Unfortunately, early diagnosis and optimal treatment of DM can be challenging, due to the lack of established clinical guidelines as well as the medical complexity of this patient population. We conducted an exploratory review of relevant literature to provide an up-to-date review for internists and hepatologists caring for this patient population. We reviewed the epidemiological and pathophysiological associations between DM and CLD, the impact of insulin resistance on the progression and manifestations of CLD, the pathogenesis of hepatogenic diabetes, as well as the practical challenges in diagnosis and monitoring of DM in this patient population. We also reviewed the latest clinical evidence on various pharmacological antihyperglycemic therapies with an emphasis on liver disease-related clinical outcomes. Finally, we proposed an algorithm for managing DM in patients with CLD and discussed the clinical and research questions that remain to be addressed. 相似文献
62.
63.
目的:观察健脾疏肝降脂方治疗非酒精性脂肪肝(NAFLD)肥胖小鼠ALT、AST、FFA及光镜下病理组织学改变,并与壳脂胶囊治疗组比较,观察其疗效。方法:将72只小鼠随机分为模型组、健脾疏肝降脂方高、中、低剂量组、壳脂胶囊对照组和空白组。采用饲养高脂饲料及皮下注射5%CCl4复制NAFLD肥胖小鼠模型,分别以相应药物灌胃6周,检测血清中ALT、AST及FFA的含量,光镜下观察肝组织的脂肪变程度。结果:①各个用药组相比模型组,血清ALT、AST均降低有统计学意义(P<0.01),且中药各浓度组较壳脂胶囊组血清ALT、AST降低,差异有统计学意义(P<0.05); 中药高、中剂量组相比模型组FFA降低,比较有统计学意义(P<0.05); 但与壳脂胶囊组相比,中药各剂量组改善FFA,差异无明显统计学意义(P>0.05)。②光镜可见:各用药组光镜下病理组织改变均较模型组明显,以中、高剂量组较低剂量组小鼠肝细胞脂肪变程度减轻较明显。结论:健脾疏肝降脂方能有效降低NAFLD肥胖小鼠的肝功能、其与浓度无关; 可以降低FFA及改善光镜下肝脏的脂肪变,其有效程度与浓度有一定的关系。 相似文献
64.
65.
66.
This article reports a patient with acquired hepatocerebral degeneration that presented with progressive cerebellar ataxia, cerebellar atrophy, and middle cerebellar peduncle lesions. He had a marked improvement after liver transplantation. We reinforce that hepatic failure should be investigated in patients with pure cerebellar syndrome, resembling neurodegenerative diseases. 相似文献
67.
68.
69.
70.
Tej I Mehta Simcha Weissman Brian M Fung James H Tabibian 《World journal of hepatology》2020,12(4):116-124
Primary sclerosing cholangitis (PSC) is a chronic, progressive, hepatobiliary disease characterized by inflammation and fibrosis of the intra- and extra-hepatic bile ducts. Its natural history is one that generally progresses towards cirrhosis, liver failure, cholangiocarcinoma, and ultimately disease-related death, with a median liver transplantation-free survival time of approximately 15-20 years. However, despite its lethal nature, PSC remains a heterogenous disease with significant variability in outcomes amongst different regions of the world. There are also many regions where the outcomes of PSC have not been studied, limiting the overall understanding of this disease worldwide. In this review, we present the geoepidemiologic variations in outcomes of PSC, with a focus on survival pre- and post-liver transplantation as well as the concurrence of inflammatory bowel disease and hepatobiliary neoplasia. 相似文献